+86-0755 2308 4243
DOTA-E-[c(RGDfK)2]

DOTA-E-[c(RGDfK)2]

Tus lej naj npawb: BRS16055

DOTA-E-[c(RGDfK)2] yog ib qho dimeric peptide uas muaj RGD sib lawv liag, siv los ua ib qho integrin ligand rau radiolabeling thiab positron emission tomography (PET) imaging. Nws yog siv nyob rau hauv vascular thiab qog kev tshawb fawb los kawm angiogenesis thiab integrin-txog cov txheej txheem.

 

Specifications

Sequence ib tsab ntawv code

DOTA-E-[c(RGDfK)2]

Sequence peb tsab ntawv code

DOTA-Glu-[cyclo (Arg-Gly-Asp-d-Phe-Lys)]

CAS Nr

N/A

Molecular Formula

C75H113N23O23

Molecular Luj

1704.88

Kev hloov kho

Cyclization, DOTA

Purity

Peak Area los ntawm HPLC Ntau dua lossis sib npaug li 95%

Daim ntawv

Lyophilized

Ntev Cia

- 20 degree lossis qis dua

Rau kev tshawb fawb siv nkaus xwb.

 

Cov ntaub ntawv:

1. Lopez-Rodriguez, V., Gaspar-Carcamo, RE, Pedraza-Lopez, M., Rojas-Calderon, EL, Arteaga de Murphy, C., Ferro-Flores, G., & Avila-Rodriguez, MA (2015 ). Kev npaj thiab kev soj ntsuam ua ntej ntawm 66Ga-DOTA-E(c(RGDfK))₂ raws li qhov muaj peev xwm theranostic radiopharmaceutical. Nuclear Medicine thiab Biology, 42(2), 109-114.

2. Siitonen, R., Peuhu, E., Autio, A., Liljenbäck, H., Mattila, E., Metsälä, O., Käkelä, M., Saanijoki, T., Dijkgraaf, I., Jalkanen, S. ., Ivaska, J., & Roivainen, A. (2019). 68Ga-DOTA-E[c(RGDfK)]2 PET Imaging of SHARPIN-Regulated Integrin Activity nyob rau hauv nas. Phau ntawv Journal of Nuclear Medicine, 60(10), 1380–1387.

 

Cim npe nrov: dota-e-[c(rgdfk)2], dota-e-[c(rgdfk)2] xa khoom

Xa kev nug

(0/10)

clearall